Ocular Drug Delivery System
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 January 2026 | Viewed by 48
Special Issue Editors
Interests: ocular drug delivery; tear biomarkers; biomaterials
Interests: drug delivery systems; nanoparticles; biodegradable nanoparticles; neurodegenerative diseases; ocular drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue on ocular drug delivery systems delves into the advancements and challenges in developing effective methods for treating several ocular diseases. Delivering drugs to the eye is fraught with difficulties due to its complex anatomical and physiological barriers, which hinder the delivery of therapeutic agents in adequate concentrations and for sufficient durations. This Special Issue aims to spotlight innovations that address these barriers, focusing on improving bioavailability, enhancing drug stability, and ensuring targeted delivery to specific ocular tissues. Recent progress in ocular drug delivery systems, including non-invasive and minimally invasive approaches, offers new hope for better patient outcomes. This Special Issue will cover cutting-edge developments in the field, from advanced materials for drug formulation to novel delivery methods, such as sustained-release systems, gene therapy, and retinal drug delivery. Research on diseases like age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and dry eye syndrome will also be explored, with emphasis on the need for personalized treatments that reduce side effects and improve patient compliance. This Special Issue invites the submission of high-quality research and review articles that address both basic science and clinical translation in ocular drug delivery. Its contributions will range from basic research on delivery mechanisms to translational studies and clinical applications, reflecting the interdisciplinary nature of this vital field in ophthalmology.
Dr. Xin Fan
Prof. Dr. Elena Sánchez-López
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- nanoparticles
- controlled release
- hydrogels
- liposomes
- microneedle arrays
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
